Ameriprise’s Codexis CDXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.54M | Sell |
3,400,496
-393,078
| -10% | -$560K | ﹤0.01% | 2364 |
|
|
2025
Q4 | $6.18M | Buy |
3,793,574
+1,019,928
| +37% | +$2.08M | ﹤0.01% | 2284 |
|
|
2025
Q3 | $6.77M | Buy |
2,773,646
+222,840
| +9% | +$608K | ﹤0.01% | 2195 |
|
|
2025
Q2 | $6.22M | Buy |
2,550,806
+16,099
| +0.6% | +$37.8K | ﹤0.01% | 2191 |
|
|
2025
Q1 | $6.82M | Buy |
2,534,707
+135,057
| +6% | +$524K | ﹤0.01% | 2066 |
|
|
2024
Q4 | $11.4M | Buy |
2,399,650
+12,625
| +0.5% | +$52K | ﹤0.01% | 1696 |
|
|
2024
Q3 | $7.35M | Buy |
2,387,025
+384,280
| +19% | +$1.19M | ﹤0.01% | 2075 |
|
|
2024
Q2 | $6.21M | Buy |
2,002,745
+703,672
| +54% | +$2.26M | ﹤0.01% | 2139 |
|
|
2024
Q1 | $4.53M | Buy |
1,299,073
+66,900
| +5% | +$211K | ﹤0.01% | 2430 |
|
|
2023
Q4 | $3.76M | Sell |
1,232,173
-555,469
| -31% | -$1.19M | ﹤0.01% | 2547 |
|
|
2023
Q3 | $3.38M | Buy |
1,787,642
+1,081,197
| +153% | +$2.53M | ﹤0.01% | 2563 |
|
|
2023
Q2 | $1.98M | Sell |
706,445
-82,200
| -10% | -$266K | ﹤0.01% | 2880 |
|
|
2023
Q1 | $3.26M | Sell |
788,645
-27,429
| -3% | -$144K | ﹤0.01% | 2592 |
|
|
2022
Q4 | $3.8M | Sell |
816,074
-1,144,814
| -58% | -$6.28M | ﹤0.01% | 2472 |
|
|
2022
Q3 | $11.9M | Buy |
1,960,888
+358,022
| +22% | +$2.88M | ﹤0.01% | 1533 |
|
|
2022
Q2 | $16.8M | Sell |
1,602,866
-1,148,573
| -42% | -$14.4M | 0.01% | 1339 |
|
|
2022
Q1 | $56.7M | Buy |
2,751,439
+408,417
| +17% | +$8.46M | 0.02% | 742 |
|
|
2021
Q4 | $73.3M | Buy |
2,343,022
+316,610
| +16% | +$10.4M | 0.02% | 674 |
|
|
2021
Q3 | $47.2M | Buy |
2,026,412
+397,326
| +24% | +$9.4M | 0.02% | 793 |
|
|
2021
Q2 | $36.9M | Buy |
1,629,086
+606,982
| +59% | +$13.2M | 0.01% | 939 |
|
|
2021
Q1 | $23.4M | Sell |
1,022,104
-1,415
| -0.1% | -$33.1K | 0.01% | 1203 |
|
|
2020
Q4 | $22.3M | Buy |
1,023,519
+259,100
| +34% | +$4.26M | 0.01% | 1157 |
|
|
2020
Q3 | $8.97M | Sell |
764,419
-45
| -0% | -$561 | ﹤0.01% | 1632 |
|
|
2020
Q2 | $8.71M | Buy |
764,464
+990
| +0.1% | +$11.2K | ﹤0.01% | 1637 |
|
|
2020
Q1 | $8.52M | Buy |
763,474
+40,984
| +6% | +$573K | ﹤0.01% | 1508 |
|
|
2019
Q4 | $11.6M | Buy |
722,490
+88,777
| +14% | +$1.31M | ﹤0.01% | 1623 |
|
|
2019
Q3 | $8.69M | Buy |
633,713
+174,764
| +38% | +$2.75M | ﹤0.01% | 1810 |
|
|
2019
Q2 | $8.46M | Sell |
458,949
-120,738
| -21% | -$2.33M | ﹤0.01% | 1859 |
|
|
2019
Q1 | $11.9M | Buy |
579,687
+117,043
| +25% | +$2.27M | 0.01% | 1552 |
|
|
2018
Q4 | $7.73M | Buy |
462,644
+89,795
| +24% | +$1.55M | ﹤0.01% | 1811 |
|
|
2018
Q3 | $6.39M | Buy |
372,849
+234,909
| +170% | +$3.79M | ﹤0.01% | 2183 |
|
|
2018
Q2 | $1.99M | Buy |
137,940
+12,140
| +10% | +$158K | ﹤0.01% | 2736 |
|
|
2018
Q1 | $1.38M | Buy |
125,800
+30,300
| +32% | +$290K | ﹤0.01% | 2832 |
|
|
2017
Q4 | $798K | Buy |
+95,500
| New | +$661K | ﹤0.01% | 3062 |
|
|
2013
Q3 | – | Sell |
-690
| Closed | -$2K | – | 5610 |
|
|
2013
Q2 | $2K | Buy |
+690
| New | +$1.56K | ﹤0.01% | 5323 |
|
Other funds holding CDXS
OM
NCM
TAM
VCM
Ameriprise's CDXS Position: Q1 2026 in Review
Ameriprise reduced its Codexis (CDXS) stake by 10% in Q1 2026, selling an estimated $560K and leaving 3,400,496 shares worth $5.54M. The position accounts for ﹤0.01% of the portfolio, ranked #2364.
Ameriprise first reported a position in CDXS in Q2 2013 and has held it in 35 quarters since. The position peaked at $73.3M in Q4 2021. 135 funds tracked by Wall St. Rank hold CDXS as of Q1 2026.
- Ameriprise held 3,400,496 shares of Codexis worth $5.54M as of Q1 2026.
- Ameriprise sold 393,078 Codexis shares in Q1 2026, an estimated $560K.
- Codexis made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #2364 holding.
- Ameriprise first reported a position in Codexis in Q2 2013 and has held it in 35 quarters since.
- Ameriprise's Codexis position peaked at $73.3M in Q4 2021.
- 135 funds tracked by Wall St. Rank held Codexis as of Q1 2026.
Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.